Psoriasis care: new and emerging pharmacologic trends. - Wikidata - wikimedia - TriplyDB

Psoriasis care: new and emerging pharmacologic trends.

Psoriasis care: new and emerging pharmacologic trends.

http://www.wikidata.org/entity/Q37757329

about

A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab.Voclosporin as a treatment for noninfectious uveitis.

P2860

Q28082166-97854280-6A89-4E26-AD72-F049F9E01AF9 Q34502118-89A7D2AA-1393-4EDC-9CD6-2CFCAF8E0BB9 Q40697533-424088B5-DB49-4C8C-AE84-C5E9ED309C1E

P2860

Psoriasis care: new and emerging pharmacologic trends.

http://www.wikidata.org/entity/Q37757329

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Psoriasis care: new and emerging pharmacologic trends.

@en

Psoriasis care: new and emerging pharmacologic trends.

@nl

type

label

Psoriasis care: new and emerging pharmacologic trends.

@en

Psoriasis care: new and emerging pharmacologic trends.

@nl

prefLabel

Psoriasis care: new and emerging pharmacologic trends.

@en

Psoriasis care: new and emerging pharmacologic trends.

@nl

P1433

Q37757329-46336EAB-AC19-4E84-AFB2-182CA8883E09

P1476

Q37757329-54FC7AFE-8F77-4379-851B-A0D464C2C0FB

P2093

Q37757329-5C0CC4EB-04B9-4BD2-96A3-3CC25328CD97

Q37757329-D4FFE886-B0D4-467E-BF59-E7CA3313BCD8

P2860

Q37757329-01409AD0-D237-4073-899B-1A16410F0FDD

Q37757329-014840F4-547E-4FCF-B053-A21D97752EA8

Q37757329-12689479-10A2-4DEC-9068-C6A4B7D877BB

Q37757329-1B45F176-B53F-44D2-847C-A5358BFE3FC5

Q37757329-31CAA8A7-F9B4-4928-AA12-F0711EE45D72

Q37757329-3B034BDA-7BB3-426D-BDFA-475C8133ADD3

Q37757329-3FF28CB1-7574-457B-A7ED-B9B463534182

Q37757329-48E8D65F-1929-4A7D-ADFB-C5FE365E03CA

Q37757329-4B4EEECD-C25E-4937-9196-C691C73439A5

Q37757329-519E3EC2-BCAA-4B1E-8525-2192BEEBCB0E

P304

Q37757329-435B402C-A7CF-47EF-8730-E28C58CE5ACF

P31

Q37757329-FE1383D1-FE7F-4741-9D94-91852882CACC

P356

Q37757329-379FF37B-25D6-4210-96A7-0FB5FEA46B4F

P433

Q37757329-CF1EC51C-06FD-4F88-9A4F-631BDEDAFCA2

P478

Q37757329-677EA6D7-B8F6-4689-8CC7-BCDD3190A587

P577

Q37757329-FDDBC733-DE23-4B84-8104-92D35F331B7F

P698

Q37757329-92DC8CF0-FB6E-4991-BAE6-87F0894BF39C

P921

Q37757329-9C8ACC93-DDF5-46B6-99A8-964B34354B2E

P356

7750.2010.09039

P1433

Journal of cutaneous medicine and surgery

P1476

Psoriasis care: new and emerging pharmacologic trends.

@en

P2093

Kim A Papp

http://www.w3.org/2001/XMLSchema#string

Wayne Carey

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Development, cytokine profile and function of human interleukin 17-producing helper T cells

Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.

Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities.

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.

P304

119-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2310/7750.2010.09039

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20487672

http://www.w3.org/2001/XMLSchema#string

P921